title: Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury.
abstract: Exposure of neonatal mice to hyperoxia results in pulmonary vascular remodeling and aberrant phosphodiesterase type 5 (PDE5) signaling. Although glucocorticoids are frequently utilized in the NICU, little is known about their effects on the developing pulmonary vasculature and on PDE5. We sought to determine the effects of hydrocortisone (HC) on pulmonary vascular development and on PDE5 in a neonatal mouse model of hyperoxic lung injury.
  
  
  
  C57BL/6 mice were placed in 21% O2 or 75% O2 within 24 h of birth and received HC (1, 5, or 10 mg/kg subcutaneously every other day) or vehicle. At 14 d, right ventricular hypertrophy (RVH), medial wall thickness (MWT), lung morphometry, and pulmonary artery (PA) PDE5 activity were assessed. PDE5 activity was measured in isolated pulmonary artery smooth muscle cells exposed to 21 or 95% O2 ± 100 nmol/l HC for 24 h.
  
  
  
  Hyperoxia resulted in alveolar simplification, RVH, increased MWT, and increased PA PDE5 activity. HC decreased hyperoxia-induced RVH and attenuated MWT. HC had dose-dependent effects on alveolar simplification. HC decreased hyperoxia-induced PDE5 activity both in vivo and in vitro.
  
  
  
  HC decreases hyperoxia-induced pulmonary vascular remodeling and attenuates PDE5 activity. These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature.
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Marta
authors.initials: M
authors.lastname: Perez
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Kamila
authors.initials: K
authors.lastname: Wisniewska
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Keng Jin
authors.initials: KJ
authors.lastname: Lee
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Herminio J
authors.initials: HJ
authors.lastname: Cardona
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Joann M
authors.initials: JM
authors.lastname: Taylor
authors.affiliation: Department of Pediatrics, Northwestern University, Chicago, Illinois.
authors.forename: Kathryn N
authors.initials: KN
authors.lastname: Farrow
mesh_terms: D000818:Animals; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004549:Elastin / Q000378:metabolism; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D018496:Hyperoxia / Q000378:metabolism / Q000473:pathology*; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D017380:Hypertrophy, Right Ventricular / Q000503:physiopathology; D008168:Lung / Q000254:growth & development* / Q000473:pathology; D055370:Lung Injury / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D011650:Pulmonary Alveoli / Q000378:metabolism; D011651:Pulmonary Artery / Q000473:pathology; D015398:Signal Transduction
chemical_list: D005938:Glucocorticoids; D004549:Elastin; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006854:Hydrocortisone